Global blood purification equipment market will reach $21.08 billion by 2031, growing by 5.5% annually over 2021-2031, driven by the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic.
Highlighted with 81 tables and 76 figures, this 154-page report Global Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication (Renal Diseases, Sepsis, Others), End User (Hospitals and Clinics, Dialysis Centers, Others), and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global blood purification equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global blood purification equipment market in every aspect of the classification from perspectives of Product, Portability, Indication, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Hemodialysis Device
Blood Filtration Device
CRRT Device
Hemoperfusion Device
Plasma Exchange Device
Other Products

Based on Portability, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Portable Equipment
Stationary Equipment

Based on Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Renal Diseases
Sepsis
Other Indications

Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Hospitals and Clinics
Dialysis Centers
Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
North America (U.S., Canada, and Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
South America (Brazil, Chile, Argentina, Rest of South America)
MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Portability, Indication, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aethlon Medical, Inc.
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Cerus Corporation
CytoSorbents Corporation
Fresenius SE and Co. KGaA
Healthwell Medical Tech. Co., Ltd.
Infomed SA
Jafron Biomedical Co., Ltd.
Kaneka Corporation
Nikkiso Co., Ltd.
Spectral Medical Inc.
SWS Medical Group
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)